Inventor · disambiguated record
Alistair James Stewart
Also filed as: STEWART ALISTAIR · STEWART ALISTAIR J · STEWART ALISTAIR JAMES
15 granted patents·12 pending applications·274 citations·filing 2004–2020
92Inventor score
Files withIDENIX PHARMACEUTICALS INC9IDENIX PHARMACEUTICALS LLC9TESARO INC3GOZES ILLANA2MERCK SHARP & DOHME1
Top patents by PatentIndex Score
27 records- 0198US9211300B24′-fluoro nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Dec 15, 2015·66 cites·23 claims
- 0297US9187515B22′,4′-fluoro nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Nov 17, 2015·51 cites·16 claims
- 0396US9309275B23′-deoxy nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted Apr 12, 2016·28 cites·24 claims
- 0496US9109001B23′,5′-cyclic phosphoramidate prodrugs for HCV infectionIDENIX PHARMACEUTICALS INC·Filed 2013·Granted Aug 18, 2015·60 cites·28 claims
- 0593US9339541B2Thiophosphate nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS INC·Filed 2014·Granted May 17, 2016·36 cites·20 claims
- 0686US8324166B2Neuroprotection using NAP-like and SAL-like peptide mimeticsGOZES ILLANA·Filed 2010·Granted Dec 4, 2012·10 cites·10 claims
- 0783US8093379B2Macrocyclic serine protease inhibitorsMOUSSA ADEL·Filed 2009·Granted Jan 10, 2012·16 cites·18 claims
- 0879US7960428B2Enantiomerically pure phosphoindoles as HIV inhibitorsIDENIX PHARMACEUTICALS INC·Filed 2007·Granted Jun 14, 2011·3 cites·42 claims
- 0977US10251903B2Process for making nucleoside phosphoramidate compoundsMERCK SHARP & DOHME·Filed 2015·Granted Apr 9, 2019·2 cites·8 claims
- 1073US10683321B24′-or nucleosides for the treatment of HCVIDENIX PHARMACEUTICALS LLC·Filed 2014·Granted Jun 16, 2020·2 cites·17 claims
- 1169US10717758B2D-amino acid compounds for liver diseaseIDENIX PHARMACEUTICALS LLC·Filed 2018·Granted Jul 21, 2020·0 cites·24 claims
- 1259US2021038585A1Niraparib formulationsTESARO INC·Filed 2020·Application pending·0 cites
- 1356US10513534B22′-chloro nucleoside analogs for HCV infectionIDENIX PHARMACEUTICALS LLC·Filed 2013·Granted Dec 24, 2019·0 cites·60 claims
- 1456US2016280729A1Cyclopentane and cyclopentene nucleoside analogs for the treatment of hcvIDENIX PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1556US2013315868A1D-amino acid compounds for liver diseaseIDENIX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1651US12297184B2Niraparib saltsTESARO INC·Filed 2019·Granted May 13, 2025·0 cites·15 claims
- 1751US2020016142A1Niraparib formulationsTESARO INC·Filed 2019·Application pending·0 cites
- 1851US2013123186A1Neuroprotection using nap-like and sal-like peptide mimeticsGOZES ILLANA·Filed 2012·Application pending·0 cites
- 1950US8486991B2Enantiomerically pure phosphoindoles as HIV inhibitorsSTORER RICHARD·Filed 2011·Granted Jul 16, 2013·0 cites·22 claims
- 2047US2016002281A1D-amino acid compounds for liver diseaseIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 2146US10723754B22′,4′-bridged nucleosides for HCV infectionIDENIX PHARMACEUTICALS LLC·Filed 2013·Granted Jul 28, 2020·0 cites·16 claims
- 2246US2016271162A1D-alanine phosphoramide pronucleotides of 2'-methyl 2'-fluro guanosine nucleoside compounds for the treatment of hcvIDENIX PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 2346US2005059632A1Synthesis of beta-L-2'-deoxy nucleosidesFiled 2004·Application pending·0 cites
- 2442US2016083413A12'-chloro nucleoside analogs for hcv infectionIDENIX PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 2541US2013217644A1Pharmaceutical Compositions of 2'-C-Methyl-Guanosine, 5'-[2[(3-Hydroxy-2,2-Dimethyl-1-Oxopropyl)Thio]Ethyl N-(Phenylmethyl)Phosphoramidate]IDENIX PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2634US2017066779A1Solid forms of a flaviviridae virus inhibitor compound and salts thereofIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 2730US2017066795A1Solid prodrug forms of 2'-chloro-2'-methyl uridine for hcvIDENIX PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →